These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3569862)

  • 41. [Insulin-dependent diabetes mellitus and MHC].
    Yamagata K; Hanafusa T
    Nihon Rinsho; 1991 Feb; 49 Suppl():525-30. PubMed ID: 2033846
    [No Abstract]   [Full Text] [Related]  

  • 42. The type 1 diabetes - HLA susceptibility interactome--identification of HLA genotype-specific disease genes for type 1 diabetes.
    Brorsson C; Tue Hansen N; Bergholdt R; Brunak S; Pociot F
    PLoS One; 2010 Mar; 5(3):e9576. PubMed ID: 20221424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The association of the HLA-A*24:02, B*39:01 and B*39:06 alleles with type 1 diabetes is restricted to specific HLA-DR/DQ haplotypes in Finns.
    Mikk ML; Heikkinen T; El-Amir MI; Kiviniemi M; Laine AP; Härkönen T; Veijola R; Toppari J; Knip M; Ilonen J;
    HLA; 2017 Apr; 89(4):215-224. PubMed ID: 28185422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: II. Haplotype effects. DiMe Study Group. Childhood Diabetes in Finland.
    Thomas D; Pitkäniemi J; Langholz B; Tuomilehto-Wolf E; Tuomilehto J
    Genet Epidemiol; 1995; 12(5):455-66. PubMed ID: 8557178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus.
    Sanjeevi CB; Lybrand TP; Landin-Olsson M; Kockum I; Dahlquist G; Hagopian WA; Palmer JP; Lernmark A
    Tissue Antigens; 1994 Aug; 44(2):110-9. PubMed ID: 7817375
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A second component of HLA-linked susceptibility to type 1 diabetes maps to class I region.
    Kawabata Y; Ikegami H; Fujisawa T; Noso S; Asano K; Hiromine Y; Ogihara T
    Ann N Y Acad Sci; 2006 Oct; 1079():278-84. PubMed ID: 17130566
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunogenetics of insulin-dependent juvenile diabetes.
    Dausset J; Hors J
    Diabetes Res; 1984 Sep; 1(3):115-23. PubMed ID: 6085045
    [No Abstract]   [Full Text] [Related]  

  • 48. Estimation of transmission probabilities in families ascertained through a proband with variable age-at-onset disease: application to the HLA A, B and DR loci in Finnish families with type 1 diabetes. The DiMe Study Group.
    Pitkäniemi J; Onkamo P; Arjas E; Tuomilehto-Wolf E; Tuomilehto J
    Hum Hered; 2000; 50(5):308-17. PubMed ID: 10878475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HLA and insulin-dependent diabetes mellitus in Koreans.
    Rhee BD; Choi SJ; Park SW; Choi DS; Han H; Kim GR; Kim SY; Cho BY; Lee HK; Koh CS
    Korean J Intern Med; 1987 Jul; 2(2):135-9. PubMed ID: 3154825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Susceptibility to type I diabetes: HLA-DQ and DR revisited.
    She JX
    Immunol Today; 1996 Jul; 17(7):323-9. PubMed ID: 8763818
    [No Abstract]   [Full Text] [Related]  

  • 51. Analysis of negative and multiple HLA antigen disease associations.
    Thomson G; Nicholas FW; Bodmer WF; O'Neill ME; Hedrick PW; Hudes E
    Tissue Antigens; 1985 Nov; 26(5):293-306. PubMed ID: 3867175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. T cell defined HLA epitopes and T cell receptor polymorphism in insulin dependent diabetes mellitus.
    Sheehy MJ
    Baillieres Clin Endocrinol Metab; 1991 Jun; 5(2):341-55. PubMed ID: 1716435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lights and shadows in the genetics of insulin-dependent diabetes mellitus].
    Iannolillo A; Torella R
    Recenti Prog Med; 1986 May; 77(5):267-70. PubMed ID: 3461511
    [No Abstract]   [Full Text] [Related]  

  • 55. Characteristics of a multiplex IDDM sample: unexplained differences with other samples.
    Falk CT
    Genet Epidemiol; 1989; 6(1):95-100. PubMed ID: 2499506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Susceptibility alleles at HLA-DRB1, -DQA1, and -DQB1 loci in Ethiopian childhood insulin-dependent diabetes mellitus.
    Abdulkadir J; Worku Y; Giphart MJ; Telahun M; Roep BO; Ottenhoff TH; Schreuder GM
    Hum Immunol; 1994 Oct; 41(2):171-2. PubMed ID: 7860364
    [No Abstract]   [Full Text] [Related]  

  • 57. [The role of the HLA system in the genetics of Type I diabetes mellitus].
    Deschamps I; Khalil I
    Diabete Metab; 1992; 18(4):253-63. PubMed ID: 1459312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship of type 1 diabetes to ancestral proportions and HLA DR/DQ alleles in a sample of the admixed Cuban population.
    Diaz-Horta O; Cintado A; Fernandez-De-Cossio ME; Nazabal M; Ferrer A; Roca J; Camacho H; Benítez J; Ale M; Villarreal A; Molina G; Vera M; Cabrera-Rode E; Novoa L
    Ann Hum Biol; 2010 Nov; 37(6):778-88. PubMed ID: 20569042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes.
    Parry CS; Brooks BR
    Biol Direct; 2008 Oct; 3():42. PubMed ID: 18854049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular basis and functional importance of some disease-associated HLA polymorphisms.
    Thorsby E; Lundin KE; Rønningen KS; Sollid LM; Vartdal F
    Tissue Antigens; 1989 Jul; 34(1):39-49. PubMed ID: 2683208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.